RobleePAllenMD

Pulmonology • Sacramento, CA

Critical Care Medicine, Pleural Disease

Professor, Internal Medicine, UC, Davis School of Medicine

Join to view full profile

Dr. Allen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Allen's full profile

Already have an account?

Office
2315 Stockton Blvd
Main Hospital
Sacramento, CA 95817
Phone+1 916-734-3564

Fax+1 916-734-7924
Is this information wrong?

Education & Training

University of California Davis HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1984
Tulane UniversityResidency, Internal Medicine, 1978 - 1980
Medical University of South CarolinaClass of 1978

Certifications & Licensure

CA State Medical License 1982 - 2024
LA State Medical License 1978 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Super Doctor SuperDoctors.com

Clinical Trials

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2006 May 01
Completed
Phase 4
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension Start of enrollment: 2009 Dec 01
Completed
Phase 3
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
Completed
Phase 2
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Start of enrollment: 2014 May 31
Completed
Phase 2
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis Start of enrollment: 2016 Feb 01
Withdrawn
Phase 2
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
Terminated
Phase 3
Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004 Start of enrollment: 2019 Apr 10
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil.
Franck Rahaghi, Roblee P Allen, Vijay Balasubramanian, Murali M. Chakinala, Jean M. Elwing, Jeremy Feldman, Peter J. Leary, Franz Rischard, Zeenat Safdar, Namita Sood,...> ;Pulmonary Pharmacology & Therapeutics. 2021 Feb 1
205 citations
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Aaron B. Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, Ashwin Ravichandran, Peter A. Engel, Abubakr Bajwa, Roblee P Allen, Jeremy Feldman, Rahul G. Argula, ...> ;The New England Journal of Medicine. 2021 Jan 28
1 citations
Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics:
R. James White, Keyur Parikh, Roblee P Allen, Jeremy Feldman, Carlos Jerjez-Sanchez, Lei Pan, Anne Keogh, C. Dario Vizza, Shelley Shapiro, Kathryn Gordon, Meredith Bro...> ;Pulmonary Circulation. 2020 Dec 8
69 citations
Combination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trial
R. James White, Carlos Jerjes-Sánchez, Gisela Martina Bohns Meyer, Tomas Pulido, Pablo Sepúlveda, Kuo Yang Wang, Ekkehard Grünig, Shirish Hiremath, Zaixin Yu, Gangchen...> ;American Journal of Respiratory and Critical Care Medicine. 2020 Mar 15
29 citations
Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation.
Franck Rahaghi, Jeremy Feldman, Roblee P Allen, Victor F. Tapson, Zeenat Safdar, Vijay Balasubramanian, Shelley Shapiro, Michael A. Mathier, Jean M. Elwing, Murali M. ...> ;Pulmonary Circulation. 2017 Mar 21
A Diagnosis at Hand: Pulmonary Arterial Hypertension.
Kavita B Khaira, Roblee P Allen, Ezra A. Amsterdam> ;The American Journal of Medicine. 2016 Aug 1
15 citations
Balloon dilation atrial septostomy for advanced pulmonary hypertension in patients on prostanoid therapy.
Brooks Kuhn, Usman Javed, Ehrin J. Armstrong, Gagan D. Singh, Thomas W. Smith, Charles Whitcomb, Roblee P Allen, Jason H. Rogers> ;Catheterization and Cardiovascular Interventions. 2015 May 1
8 citations
Exhaled volatile organic compounds in individuals with a history of high altitude pulmonary edema and varying hypoxia-induced responses.
Jennifer Ann Figueroa, Jim K. Mansoor, Roblee P Allen, Cristina E. Davis, William F. Walby, Alexander A. Aksenov, William R. Lewis, Edward S. Schelegle> ;Journal of Breath Research. 2015 Apr 20
6 citations
Diverse forms of pulmonary hypertension remodel the arterial tree to a high shear phenotype
Roblee P Allen, Edward S. Schelegle, Stephen H. Bennett> ;American Journal of Physiology. Heart and Circulatory Physiology. 2014 Aug 1
32 citations
Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertension
Jim K. Mansoor, Edward S. Schelegle, Cristina E. Davis, William F. Walby, Weixiang Zhao, Alexander A. Aksenov, Alberto Pasamontes, Jennifer Ann Figueroa, Roblee P Allen> ;Plos One. 2014 Apr 18
196 citations
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inh...
Victor F Tapson, Zhi-Cheng Jing, Kai-Feng Xu, Lei Pan, Jeremy Feldman, David G Kiely, Eugene Kotlyar, C Shane McSwain, Kevin Laliberte, Carl Arneson, Lewis J Rubin> ;Chest. 2013 Sep 1
26 citations
Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertension.
R. James White, Fernando Torres, Roblee P Allen, Carlos Jerjes, Tomás Pulido, David Yehle, Meredith Howell, Kevin Laliberte, Jean Francois Marier, Victor F. Tapson> ;Journal of Cardiovascular Pharmacology. 2013 Jun 1
238 citations
Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension A Randomized, Controlled Trial
Zhi-Cheng Jing, Keyur Parikh, Tomás Pulido, Carlos Jerjes-Sánchez, R. James White, Roblee P Allen, Adam Torbicki, Kai Feng Xu, David Yehle, Kevin Laliberte, Carl Arnes...> ;Circulation. 2013 Feb 5
175 citations
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibit...
Victor F Tapson, Fernando Torres, Fiona Kermeen, Anne M Keogh, Roblee P Allen, Robert P Frantz, David B Badesch, Adaani E Frost, Shelley M Shapiro, Kevin Laliberte, Je...> ;Chest. 2012 Dec 1
50 citations
6.6-hour inhalation of ozone concentrations from 60 to 87 parts per billion in healthy humans.
Edward S. Schelegle, Christopher A. Morales, William F. Walby, Susan M. Marion, Roblee P Allen> ;American Journal of Respiratory and Critical Care Medicine. 2009 Aug 1
22 citations
Do airway metallic stents for benign lesions confer too costly a benefit
Andrew L. Chan, Maya Juarez, Roblee P Allen, Timothy E Albertson> ;BMC Pulmonary Medicine. 2008 Apr 18
72 citations
Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial
Melvyn Rubenfire, Vallerie V. McLaughlin, Roblee P Allen, Greg Elliott, Myung H. Park, Michael Wade, Robert Schilz> ;Chest. 2007 Sep 1
35 citations
Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and muco...
Andrew L. Chan, Maya Juarez, Roblee P Allen, William G. Volz, Timothy E Albertson> ;Photodermatology, Photoimmunology & Photomedicine. 2005 Apr 1
45 citations
Bronchiolitis obliterans: an update.
Andrew L. Chan, Roblee P Allen> ;Current Opinion in Pulmonary Medicine. 2004 Mar 1
12 citations
Epoprostenol in pregnant patients with secondary pulmonary hypertension: Two case reports and a review of the literature
Mark V Avdalovic, Christian Sandrock, Andrea Hoso, Roblee P Allen, Timothy E Albertson> ;Treatments in Respiratory Medicine. 2004 Jan 1
25 citations
Bronchiolitis obliterans
Petey Laohaburanakit, Andrew L. Chan, Roblee P Allen> ;Clinical Reviews in Allergy & Immunology. 2003 Dec 1
12 citations
Advances in the management of endobronchial lung malignancies.
Andrew L. Chan, Ken Y. Yoneda, Roblee P Allen, Timothy E Albertson> ;Current Opinion in Pulmonary Medicine. 2003 Jul 1
Use of laryngeal mask airway in a patient requiring continuous positive airway pressure: a case report.
Hong Liu, Jonathan S. Jahr, A. Thornton, Roblee P Allen> ;Journal of Clinical Anesthesia. 1999 Sep 1
12 citations
Importance of an aggressive multidisciplinary management approach to optimize lung donor procurement.
David M. Follette, S. Rudich, Christine A. Bonacci, Roblee P Allen, Andrea Hoso, Timothy E Albertson> ;Transplantation Proceedings. 1999 Feb 1
3 citations
Comparison of functional state between bilateral lung volume reduction surgery and pulmonary rehabilitation: a six-month followup study.
K. Mercer, David M. Follette, E. Breslin, Roblee P Allen, Andrea Hoso, B. Volz, Timothy E Albertson> ;International Journal of Surgical Investigation. 1999 Jan 1
Join now to see all

Hospital Affiliations

UC Davis Medical CenterSacramento, California
Sacramento Veterans Affairs Medical CenterMather, California